GCC Looking To Expand Its Horizons

March 2007 | Industry News

Key growth drivers are causing an upswing in foreign direct investment (FDI) in the pharmaceutical industry in the GCC. According to recently released figures from the United Nations Conference on Trade and Development (UNCTAD), the UAE attracted 34% of total FDI to the Middle East in 2005. The good news is that the country is likely to improve on that performance this year and next, as a consequence of ongoing reform of the regulatory climate - crucial for sectors such as pharmaceuticals - and the country's growing status as a regional economic and trade hub. Meanwhile, strong investment in infrastructure

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.